 |
|
|
The clinical trial industry was facing some key challenges across the stakeholder spectrum prior toCOVID-19, and while many of the challenges remain the same some have morphed or even become emphasized in the face of the pandemic. How has Covid-19 impacted clinical studies in Europe? During this presentation, we take a look at survey data that Greenphire has gathered from sites, study sponsors and CROs over the last half year.We review how technology can be used to create value, now more than ever, in order to bring more connectivity to stakeholders across the spectrum of clinical research, from study sponsors and CROsto clinics to patients themselves.
|